The Latest Cardiac and Vascular News
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the fourth quarter and fiscal year 2025 […]
BAAR, Switzerland–(BUSINESS WIRE)–CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), which allows the pivotal clinical trial to begin at U.S. hospitals. CorFlow will now […]
SANTA MONICA, Calif., July 7, 2025 /PRNewswire/ — Lifeforce, the world’s largest longevity medicine platform, and Toku, a health technology company using AI to translate a single retinal image into real-time biological age and cardiovascular risk scores, have announced a nationwide…
TOKYO, July 7, 2025 /PRNewswire/ — Simplex Quantum, an AI-driven healthcare technology company, is proud to announce that Dr. Marco Perez, Associate Professor of Medicine at Stanford University and a renowned expert in cardiac electrophysiology, has agreed to act as an advisor to Simplex…
COPENHAGEN, Denmark, July 7, 2025 /PRNewswire/ — CathVision ApS, a medical technology company developing electrophysiology solutions for cardiac ablation, announces the market release of ECGenius™ System Version 3.4, introducing multiple software enhancements aimed at improving…
Funding, which will support clinical studies of Restore’s novel transcatheter device, was co-led by Pitango HealthTech and a global strategic partner, with continued investment from existing investors including Peregrine Ventures, another global strategic partner, and new investment from…
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, Mass., July 7, 2025 /PRNewswire/ — Sirtex Medical (“Sirtex”), a leading manufacturer of…
FORT MILL, S.C., July 07, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced today that it has received a purchase order from Centre Hospitalier Universitaire (CHU) de Rennes. This is the first purchase order from Universite de Rennes and marks the largest purchase order for the VIVO product line to date.
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to…
“Progress made in reducing heart attack deaths provides a roadmap to address rising mortality rates from arrythmias, heart failure and hypertensive heart disease” HOFFMAN ESTATES, Ill., July 3, 2025 /PRNewswire/ — Heart health leader OMRON Healthcare today issued an urgent health message…
